Cover Image

A Narrative Review on the Role of Dalbavancin in the Treatment of Bone and Joint Infections

Bone and joint infections (BJI) require prolonged antimicrobial treatment, leading to lengthy hospitalizations, high costs, the risk of nosocomial infections, and the development of antimicrobial resistance. Dalbavancin is a novel semisynthetic lipoglycopeptide approved for the treatment of adults a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dimitra Dimopoulou (Author), Elpis Mantadakis (Author), Christos Koutserimpas (Author), George Samonis (Author)
Format:	Book
Published:	MDPI AG, 2023-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review
by: Luis Buzón-Martín, et al.
Published: (2021)

Dalbavancin in Bone and Joint Infections: A Systematic Review
by: Sofia Lovatti, et al.
Published: (2023)

Current Therapeutic Approaches for Multidrug-Resistant and Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Infections
by: Petros Rafailidis, et al.
Published: (2024)

Use of Dalbavancin in Skin, Bone and Joint Infections: A Real-Life Experience in an Italian Center
by: Lucia Brescini, et al.
Published: (2021)

Antimicrobial Regimens in Cement Spacers for Periprosthetic Joint Infections: A Critical Review
by: Symeon Naoum, et al.
Published: (2024)

Dalbavancin in the treatment of skin and soft tissues infection
by: Ana Candela Fajardo, et al.
Published: (2017)

Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review
by: Jason W Bennett, et al.
Published: (2008)

Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an <i>In Vitro</i> Study
by: Mar Sánchez-Somolinos, et al.
Published: (2022)

Duration of Antimicrobial Treatment in Adult Patients with Pneumonia: A Narrative Review
by: Dimitra Dimopoulou, et al.
Published: (2024)

<i>Cellulosimicrobium</i> Infections in Humans-A Narrative Review
by: Petros Ioannou, et al.
Published: (2024)

Real-World Use of Dalbavancin for Treatment of Soft Tissue and Bone Infection in Children: Safe, Effective and Hospital-Time Sparing
by: Désirée Caselli, et al.
Published: (2024)

Genital tuberculosis in a tamoxifen-treated postmenopausal woman with breast cancer and bloody vaginal discharge
by: Maraki Sofia, et al.
Published: (2006)

Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
by: Leuthner KD, et al.
Published: (2016)

Clinical Effectiveness and Pharmacokinetics of Dalbavancin in Treatment-Experienced Patients with Skin, Osteoarticular, or Vascular Infections
by: Giacomo Stroffolini, et al.
Published: (2022)

Bacteriophages in Infectious Diseases and Beyond-A Narrative Review
by: Petros Ioannou, et al.
Published: (2023)

Infective Endocarditis by <i>Lactobacillus</i> Species-A Narrative Review
by: Petros Ioannou, et al.
Published: (2024)

In Vitro Activities of Ceftobiprole, Dalbavancin, Tedizolid and Comparators against Clinical Isolates of Methicillin-Resistant <i>Staphylococcus aureus</i> Associated with Skin and Soft Tissue Infections
by: Sofia Maraki, et al.
Published: (2023)

Successful use of dalbavancin in the treatment of gram positive blood stream infections: a case series
by: Connor Evins, et al.
Published: (2022)

Transient erythroblastopenia of childhood in a boy with celiac disease: A case report and review of the literature
by: Sonia Alexiadou, et al.
Published: (2023)

Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety
by: Andrés Ruiz-Sancho, et al.
Published: (2023)

Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care
by: Leama Ajaka, et al.
Published: (2020)

Infective Endocarditis by <i>Clostridioides</i> and <i>Clostridium</i> Species-A Narrative Review
by: Petros Ioannou, et al.
Published: (2023)

In Vitro Efficacy of Dalbavancin as a Long-Acting Anti-Biofilm Agent Loaded in Bone Cement
by: Mar Sánchez-Somolinos, et al.
Published: (2023)

Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization
by: Simonetti O, et al.
Published: (2021)

New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin
by: Juul JJ, et al.
Published: (2016)

Appropriate Duration of Antimicrobial Treatment for Prosthetic Joint Infections: A Narrative Review
by: Jaime Lora-Tamayo, et al.
Published: (2024)

Periprosthetic Joint Infection Diagnosis: A Narrative Review
by: Konstantinos Tsikopoulos, et al.
Published: (2023)

The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa
by: Elisa Molinelli, et al.
Published: (2022)

Evaluating the Use of Dalbavancin for Off-Label Indications
by: Katherine Taylor, et al.
Published: (2022)

Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs
by: Pedro Luis Gonzalez, et al.
Published: (2018)

Model-Based Dose Identification of Dalbavancin for Long-Term Suppressive Outpatient Treatment of Ventricular Assist Device Infections
by: Ute Chiriac, et al.
Published: (2024)

Methodological Challenges in Predicting Periprosthetic Joint Infection Treatment Outcomes: A Narrative Review
by: Elise Naufal, et al.
Published: (2022)

Frequency of genetic diseases and health coverage of children requiring admission in a general pediatric clinic of northern Greece
by: Lialiaris Theodoros, et al.
Published: (2010)

Nanotechnology in the Diagnosis and Treatment of Antibiotic-Resistant Infections
by: Petros Ioannou, et al.
Published: (2024)

Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections
by: Altea Gallerani, et al.
Published: (2023)

Intravenous γ Globulin for Intractable Abdominal Pain due to IgA Vasculitis
by: George Naifa, et al.
Published: (2020)

Update on Acute Bone and Joint Infections in Paediatrics: A Narrative Review on the Most Recent Evidence-Based Recommendations and Appropriate Antinfective Therapy
by: Giovanni Autore, et al.
Published: (2020)

Role of matrix metalloproteinases in bone regeneration: Narrative review
by: Christian Khoswanto
Published: (2023)

Dalbavancin for Acute Bacterial Skin and Skin Structure Infections in Pediatrics: Insights from Continuation Therapy Experience
by: Sara Maria Scarano, et al.
Published: (2024)

DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
by: Carmen Hidalgo-Tenorio, et al.
Published: (2019)